Biotech AssistantIndependent biopharma research
CHINA CLINICAL DEVELOPMENT / INTERNATIONAL BIOTECH

China Clinical CROs & IIT Partners

Compare China-based and China-origin CROs, international China operations, and separately labeled specialist partners for China trials and IITs.

Open the clinical CRO comparison map ↗Questions for partner selection ↓
15China-based / China-origin
12International CRO China operations
3Specialist / consultancy candidates
4SMO / device specialists

How to read this directory

34 service-platform records across four categories, not 34 independent Chinese full-service CROs. Group subsidiaries and renamed platforms are identified. Company disclosures establish service claims, not independent quality certification; coverage is broad but not guaranteed exhaustive. GCP ClinPlus is featured first by editorial choice.

GCP ClinPlus is featured first, with public disclosures supporting China clinical and IIT services for international clients. GCP ClinPlus, SMO ClinPlus and Proswell are separate companies.

An IIT is investigator-initiated research, not automatically a registrational trial or a guarantee of overseas regulatory acceptance. Assess the modality, objective, institution and intended submission use separately.

NIH: China clinical research regulation sources ↗ · IQVIA: China IIT versus IND discussion ↗

Reset

34 / 34 platform records; ordering is not a comparative performance ranking.

FEATURED · CHINA CLINICAL & IIT

GCP ClinPlus

Discloses China clinical operations, biometrics, regulatory and safety services, with explicit China IIT support for international developers, including cell and gene therapies. A US subsidiary and international partner network support cross-border engagement.

IIT evidence: IIT / investigator-led research explicitly disclosed

Full-service clinical Early-phase clinical Cell & gene therapy Oncology Data management & biostatistics Explicit IIT disclosure

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

GCP ClinPlus ↗ · GCP ClinPlus ↗ · GCP ClinPlus ↗

Compare and save in the member map →
China-based / China-origin

Tigermed

China-origin global clinical CRO with a disclosed Chinese investigator network and cross-regional development services. Historical offering documents reference IITs; confirm current indication-specific IIT staffing and scope.

IIT evidence: Historical IIT disclosure; current scope to confirm

Full-service clinical Cross-border / multicentre trials Oncology Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Tigermed ↗ · Tigermed ↗ · Tigermed ↗

Compare and save in the member map →
China-based / China-origin

ClinChoice

China-origin global CRO. Its China service page describes Phase I–IV work, site start-up, operations and biometrics for local and global sponsors. Global trial experience does not establish a specific IIT track record.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Oncology Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

ClinChoice ↗ · ClinChoice ↗

Compare and save in the member map →
China-based / China-origin

Caidya

International CRO incorporating China-origin dMed. Discloses China operational strength and connected development between China, the US and Europe.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Oncology Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Caidya ↗

Compare and save in the member map →
China-based / China-origin

Harvest Integrated Research Organization (HiRO)

Cross-border CRO with China operations. Team biographies reference Phase I–IV and IIT experience. Staff experience is not proof of company-level IIT delivery; verify the contracting entity and China project lead.

IIT evidence: Team IIT experience; company cases to confirm

Full-service clinical Cross-border / multicentre trials Early-phase clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Harvest Integrated Research Organization (HiRO) ↗ · Harvest Integrated Research Organization (HiRO) ↗

Compare and save in the member map →
China-based / China-origin

Pharmaron Clinical

China clinical platform within a global development network, with operations linked to SMO and recruitment teams. Distinguish China delivery from the group’s US and UK early-phase facilities.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Early-phase clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Pharmaron Clinical ↗ · Pharmaron Clinical ↗

Compare and save in the member map →
China-based / China-origin

R&G PharmaStudies

China clinical CRO with biometrics and trial management capabilities. A Medidata partnership announcement supports its clinical technology and data-standardization approach; confirm international sponsor references and IIT staffing directly.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

R&G PharmaStudies ↗ · R&G PharmaStudies ↗

Compare and save in the member map →
China-based / China-origin

Boji Medical (BojiMed)

Offers clinical operations and China–US registration services, with US development through BioTrialMed. For inbound China work, confirm local delivery, English communication and quality responsibilities separately.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Early-phase clinical

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Boji Medical (BojiMed) ↗ · Boji Medical (BojiMed) ↗

Compare and save in the member map →
China-based / China-origin

JOINN Clinical

JOINN’s corporate disclosures include clinical trials and pharmacovigilance. Verify the clinical team and contracting entity; group GLP toxicology credentials do not establish clinical GCP execution capability.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Early-phase clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

JOINN Clinical ↗ · JOINN Clinical ↗

Compare and save in the member map →
China-based / China-origin

Frontage Clinical Services

Clinical and laboratory platform with China and North America operations, including early-phase clinical services and biometrics. Assess early development fit separately from full-service registrational trial management.

IIT evidence: IIT capability not established by reviewed sources

Early-phase clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Frontage Clinical Services ↗ · Frontage Clinical Services ↗

Compare and save in the member map →
China-based / China-origin

H&J CRO International

China full-service clinical CRO disclosing a Shanghai entity and US subsidiary, targeting overseas-sponsored China studies. Confirm current staffing, sponsor references and delivery entity.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

H&J CRO International ↗

Compare and save in the member map →
China-based / China-origin

Proswell Medical

China clinical CRO with a Medidata partner profile and a Micron alliance announcement supporting international collaboration. Proswell is a separate company from GCP ClinPlus.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Proswell Medical ↗ · Proswell Medical ↗ · Proswell Medical ↗

Compare and save in the member map →
China-based / China-origin

Clinical Service Center (CSC)

China-origin CRO disclosing international branches and operations, regulatory, writing and biometrics services. Public materials describe China–US and multi-country submissions; confirm inbound China and IIT experience.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Clinical Service Center (CSC) ↗ · Clinical Service Center (CSC) ↗

Compare and save in the member map →
China-based / China-origin

Giant Med-Pharma Services

China clinical CRO whose English site describes domestic and overseas clients and hospital-initiated research involving international sites. This supports investigator-led experience, with current commercial IIT scope to confirm.

IIT evidence: IIT / investigator-led research explicitly disclosed

Full-service clinical Cross-border / multicentre trials Oncology Data management & biostatistics Explicit IIT disclosure

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Giant Med-Pharma Services ↗ · Giant Med-Pharma Services ↗

Compare and save in the member map →
China-based / China-origin

SIIP Clinical Research / Shanghai Yilinsi

SIIP’s official business page identifies Shanghai Yilinsi clinical services covering Phase I–IV, human PK, bioequivalence and international multicentre studies. Confirm English project staffing and recent overseas sponsor references.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Early-phase clinical Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

SIIP Clinical Research / Shanghai Yilinsi ↗

Compare and save in the member map →
International CRO China operations

Emerald Clinical / Hongyi Clinical

China clinical platform formerly associated with WuXi AppTec, now part of Emerald Clinical and operating as Hongyi Clinical. Consolidated with historical WuXi Clinical rather than counted as a separate current WuXi subsidiary.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Emerald Clinical / Hongyi Clinical ↗

Compare and save in the member map →
International CRO China operations

Novotech China

APAC-origin international CRO with disclosed China teams, offices and site partnerships. Relevant to biotech China delivery comparisons; IIT support requires project-level confirmation.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Oncology

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Novotech China ↗

Compare and save in the member map →
International CRO China operations

IQVIA / KunTuo China

International CRO China platform. Official materials discuss China IIT versus IND pathways and local CRO support for IITs. IQVIA and KunTuo are presented as one group platform to avoid double counting.

IIT evidence: IIT / investigator-led research explicitly disclosed

Full-service clinical Cross-border / multicentre trials Early-phase clinical Cell & gene therapy Data management & biostatistics Explicit IIT disclosure

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

IQVIA / KunTuo China ↗

Compare and save in the member map →
International CRO China operations

Parexel China

International full-service CRO with China delivery and published early-phase partner-site information. Confirm the actual team, indication and protocol rather than assuming global coverage establishes IIT fit.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Early-phase clinical

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Parexel China ↗ · Parexel China ↗

Compare and save in the member map →
International CRO China operations

ICON China

International CRO disclosing China/APAC clinical operations and a Beijing central laboratory. Contract clinical operations and laboratory scope separately; current IIT support is not established by the reviewed sources.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

ICON China ↗ · ICON China ↗

Compare and save in the member map →
International CRO China operations

PPD China (Thermo Fisher Scientific)

Thermo Fisher’s clinical research business. Its China page describes local regulatory, linguistic and operational support for development programs.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

PPD China (Thermo Fisher Scientific) ↗

Compare and save in the member map →
International CRO China operations

Fortrea China

International CRO with official China locations and a multinational oncology case study. A case example does not establish experience across every indication or IIT pathway.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Oncology

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Fortrea China ↗ · Fortrea China ↗

Compare and save in the member map →
International CRO China operations

Syneos Health China

International clinical development platform with officially listed Beijing and Shanghai offices. Assess integrated global delivery separately from local IIT scope and confirm current resources.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Syneos Health China ↗

Compare and save in the member map →
International CRO China operations

Medpace China

International full-service CRO with official evidence of Shanghai and Beijing clinical teams. Confirm current China full-service scope and IIT availability directly.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Oncology

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Medpace China ↗ · Medpace China ↗

Compare and save in the member map →
International CRO China operations

CMIC China

Japan-origin CRO whose China page describes Beijing operations, site selection and CRC support. Group physician-initiated research capability does not automatically establish China IIT delivery.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

CMIC China ↗ · CMIC China ↗

Compare and save in the member map →
International CRO China operations

EPS China / EPS International

Japan-origin EPS China CRO platform disclosing Phase I–IV, data, statistics, monitoring, regulatory and PV services. China affiliates are consolidated; confirm the actual contracting entity.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

EPS China / EPS International ↗ · EPS China / EPS International ↗

Compare and save in the member map →
International CRO China operations

Linical China

Japan-origin global CRO with China multilingual teams and clinical development disclosed on its APAC page. Confirm inbound China project scope and IIT services separately.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Linical China ↗

Compare and save in the member map →
Specialist / consultancy candidates

Vita Research

Website explicitly markets China IIT services to global developers. Evidence is primarily self-description; verify the legal entity, onshore team, site contracts, sponsor references and case records.

IIT evidence: IIT / investigator-led research explicitly disclosed

Explicit IIT disclosure Early-phase clinical Cell & gene therapy

Confirm before selection
  • Legal entity, current staffing and project delivery have not been independently validated.
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Vita Research ↗

Compare and save in the member map →
Specialist / consultancy candidates

Protheragen Clinical CRO

Markets China clinical and IIT services for global clients. Listed as a specialist candidate, not an independently validated full-service CRO; verify the China delivery entity, staffing and track record.

IIT evidence: IIT / investigator-led research explicitly disclosed

Explicit IIT disclosure Early-phase clinical Cell & gene therapy Data management & biostatistics

Confirm before selection
  • Legal entity, current staffing and project delivery have not been independently validated.
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Protheragen Clinical CRO ↗

Compare and save in the member map →
Specialist / consultancy candidates

Åström Research International

CRO/consultancy focused on Western life-science companies entering China clinical research, with disclosed university-hospital relationships. Confirm current staffing, agreement validity and operational subcontracting.

IIT evidence: IIT capability not established by reviewed sources

Cross-border / multicentre trials

Confirm before selection
  • Legal entity, current staffing and project delivery have not been independently validated.
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Åström Research International ↗

Compare and save in the member map →
SMO / device specialists

SMO ClinPlus

Primarily provides site management and CRC services for domestic and international sponsors/CROs. SMO ClinPlus is distinct from GCP ClinPlus; site support is not full-service CRO management.

IIT evidence: IIT capability not established by reviewed sources

Site management

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

SMO ClinPlus ↗ · SMO ClinPlus ↗

Compare and save in the member map →
SMO / device specialists

MedKey Clinical

Discloses SMO, evidence-based medicine and digital research support. Listed separately so site and technology services are not confused with full-service CRO delivery.

IIT evidence: IIT capability not established by reviewed sources

Site management

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

MedKey Clinical ↗ · MedKey Clinical ↗

Compare and save in the member map →
SMO / device specialists

Tigermed-Jyton

Tigermed-affiliated medical-device/IVD clinical and regulatory platform. Listed as a specialist business, not an independent group; drug IITs require separate team matching.

IIT evidence: IIT capability not established by reviewed sources

Medical devices / IVD Cross-border / multicentre trials

Confirm before selection
  • Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
  • IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Tigermed-Jyton ↗

Compare and save in the member map →

Partner-selection questions for international biotechs

  1. Delivery team: who is the named English-speaking project manager, which China entity contracts, and which functions are subcontracted?
  2. Relevant experience: request recent international sponsor references, indication/modality-matched case studies and named investigator/site availability.
  3. IIT fit: agree the investigator and institution roles, study governance, scientific objective and intended downstream use of the data before selecting a pathway.
  4. Quality and safety: review the quality system, audit history, monitoring plan, medical monitoring, PV and access to source records.
  5. Data and cross-border use: agree ownership, English outputs, database specifications, HGR/data responsibilities and any proposed overseas submission use.
  6. Execution and budget: compare site activation assumptions, recruitment feasibility, itemized costs, milestones, dependencies and change-control terms.

Use the directory for partner discovery and comparison. Investigators, institutions, sponsors and relevant professional teams must define the pathway and responsibilities for each study.

AI assistant ↗